Stage III Prostate Cancer AJCC v8
Showing 26 - 32 of 32
s Among African American Stage 0-III Prostate Cancer Survivors
Recruiting
- Cancer Survivor
- +11 more
- Accelerometer
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 21, 2022
Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 Trial in Atlanta
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +10 more
- Radiation therapy
- +2 more
-
Atlanta, Georgia
- +3 more
Jun 7, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma
Recruiting
- Bladder Small Cell Neuroendocrine Carcinoma
- +16 more
- Carboplatin
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022
Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate
Active, not recruiting
- Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
- +8 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Feb 10, 2022
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Daratumumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Pharmacogenomics Testing in Directing Optimal Use of Supportive
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +45 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Feb 3, 2022